High Technology Hospital Medcenter LLC

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Graves' disease and hyperthyroidism1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• argenx1 trial
• Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial

Running trials

• Recruiting

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

  NCT07596849· Phase 3· argenx· Source

  Contact: Inga Abesadze, MD

• Recruiting

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source

  Contact: Nana Bolkvadze (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting
• Graves' disease and hyperthyroidism1 recruiting